Tufts Clinical and Translational Research Institute

塔夫茨临床与转化研究所

• 批准号: 9140205
• 负责人: Harry P. Selker
• 金额: $ 121.73万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2016-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9140205
• 关键词: Address; Clinical; Clinical Research; Clinical Sciences; Communities; Complement; Development; Discipline; Education; Health; Health Policy; Home environment; Hospitals; Ice; Institutes; Institution; Leadership; Methods; Occupational activity of managing finances; Office of Administrative Management; Personnel Management; Policies; Public Health; Research; Research Institute; Resources; Schools; Science; Services; Structure; System; Training and Education; Translational Research; Translations; Universities; base; bench to bedside; care delivery; clinical practice; industry partner; innovation; meetings; novel; programs

Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1") translation, crucial to having health impact, translation into effective clinical practice ("T2"), care delivery and public health ("TS"), and health policy ('T4"). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench "to bedside ("Tl") translation and crucially for having health impact, translation into effective clinical practice ("T2"), care delivery and public health ("TS-), and health policy (�T4").

塔夫茨临床与转化科学研究所 (CTSl) 仍然热衷于申请我们的第二个 CTSA 致力于涉及全方位的临床和转化研究（CTR），以满足 生物医学科学，不仅是从实验室到临床 (T1") 的翻译，对健康影响至关重要，翻译 有效的临床实践（“T2”）、护理服务和公共卫生（“TS”）以及卫生政策（“T4”）。2008 年 我们在之前的 CTR 资源、服务和教育项目的基础上创办了塔夫茨 CTSl，我们有目的地 选定的合作伙伴将在战略上利用和补充彼此的特殊资产。 选定的合作伙伴包括 12 所塔夫茨大学学校/研究中心、10 家塔夫茨医院、三个学术机构 机构（布兰迪斯大学、东北大学、兰德公司），八个社区型 组织和五个行业合作伙伴，提供出色的协同资源、机会和 我们的应用程序的四个部分描述了建立在 T1-T4 范围内的四个目标。 该平台：目标 1：通过以下方式全面加强塔夫茨 CTSl：1) 组织和领导其合作伙伴 对 CTR 这个共享家园的承诺；2) 扩大所有合作伙伴对全方位的有效访问范围； 以促进跨学科和机构协作点击率的方式提供高质量资源） 通过地方和国家的领导以及新方法的开发来推进 CTR 领域；4) （第一部分）目标 2： 运营和实施 CTR 之家及其基础设施、服务和计划，包括其 中央办公室人员、行政和财务管理系统、委员会和其他 （第二部分）目标 3：维持和发展创新资源、服务和政策， 支持和促进协作、跨学科、全方位转化研究（第三部分）AIM。 4：通过 T1-T4 范围的教育和培训，发展和扩大 CTR 员工队伍， 特别关注解决从临床到临床以及从临床到广泛应用之间的转化差距 （第四节） 相关性（参见说明）： 塔夫茨临床和转化科学研究所使用整个临床和转化领域 研究（CTR），以帮助满足生物医学科学的承诺和公众的需求。这包括基准 “到床边（“Tl”）翻译，对于健康影响至关重要，转化为有效的临床实践 （“T2”）、护理服务和公共卫生（“TS-”）以及卫生政策（“T4”）。